TSCO Q1 2026 Earnings EPS Miss Sends Stock Lower Amid Cost Pressures ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress LEA Q1 2026 Earnings Earnings Per Share Surpasses Estimates on Strong Operational Performance VLYPP Q1 2026 Earnings Preferred EPS Beats Estimates Stock Declines Slightly Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues Post Holdings Q1 2026 Earnings Strong EPS Beat Masks Mixed Underlying Performance